drugset / Trial / NCT06896617
Impact of the Presence of the Corpus Luteum on Pregnancies Obtained Through Frozen Embryo Transfer(FET)
RandomizedParallel-groupOpen-labelOther
Summary
In pregnancies achieved through programmed frozen embryo transfer cycle (PC-FET) and modified natural frozen embryo transfer (mNC-FET), to determine whether there are differences in endothelial and placental function, maternal cardiovascular function, fetal growth and fetal cardiovascular and cerebral programming and to assess whether there is an association between these differences and the plasma concentrations of the main secretion products of the Corpus Luteum (CL) with vasoactive and angiogenic action.
Timeline
- Start
- 2025-02-01
- Primary completion
- 2026-11-20
- Completion
- 2026-12-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Estradiol | Other / unclassified | — | — |
| Comparator | Ovidrel | Protein / enzyme biologic | 250 ug | — |
| Comparator | Progesterone | Other / unclassified | — | — |